Fundz

Stimu Sil reported raising $575,000 in an initial SEC Form D filing, from an offering of $570,000

PRIVATEAug 12, 2022

Amount Raised

$575,000

$575,000 sold, per SEC Form D (first sale Jul 1, 2022)

Round Type

Seed

WilmingtonBiotechnology

Quick answer

StimuSIL raised $575,000 in a Seed round, dated July 1, 2022. StimuSIL is based in Wilmington, Delaware, United States.

How much did StimuSIL raise?
StimuSIL raised $575,000 in a Seed round on July 1, 2022.
What does StimuSIL do?
StimuSIL is a medical device company developing proprietary technologies for safer and more effective light therapy.
Where is StimuSIL based and how big is it?
StimuSIL is based in Wilmington, Delaware, United States.
Who are the decision-makers at StimuSIL?
Fundz holds 1 contact at StimuSIL, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as StimuSIL that raised within 45 days of this round, from Fundz verified event records.

  • Abintus Bio raised $14M on August 15, 2022.
  • ADC Therapeutics raised $175M (Convertible Note) on August 15, 2022.
  • TerraPower raised an undisclosed amount (Funding Round) on August 15, 2022.
  • Remedium Bio raised $2.3M (Seed) on August 15, 2022.
  • Monod Bio, Inc. raised $25M (Seed) on August 15, 2022.
  • Kerecis raised $1.8M (Seed) on August 15, 2022.

Who to call at StimuSIL, and when

A new round usually means StimuSIL is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day StimuSIL raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at StimuSIL, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at StimuSIL. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

StimuSIL

Location

2810 Church Street, PMB 78535

Wilmington, Delaware, United States

About

StimuSIL is a medical device company developing proprietary technologies for safer and more effective light therapy. We intend for our products to be used across multiple indications in dermatology and aesthetics. We’ve established a team of leading experts in the dermatology, aesthetics, pharmaceuticals, biomedical engineering, and regulatory science fields to lead the research and development across our medical device pipeline.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment StimuSIL raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAna V., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for StimuSIL's next move

See what Strategic adds

StimuSIL raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.